P E Patton

No ORCID on file · 6 papers in corpus
other 2004
Human Reproduction ·doi:10.1093/humrep/deh132

BACKGROUND: In a prospective study we measured circulating levels of vasoactive factors and their soluble receptors in women undergoing controlled ovarian stimulation (COS) for IVF who were at risk for ovarian hyperstimulation syndrome (OHS…

lab-animal 1997
Human Reproduction ·doi:10.1093/humrep/12.12.2756

Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) originating from the follicle or corpus luteum may be a physiological regulator of ovulation and neovascularization of luteinizing tissue, as well as a pathological …

other 1993
Fertility and sterility ·doi:10.1016/s0015-0282(16)56061-0

Our objective was the design of a catheter system that could be used in cases of a failed trial transfer. The system uses semirigid and soft-tipped materials that should allow atraumatic and reliable endometrial placement of embryos in diff…

case-report 1991
Fertility and sterility ·doi:10.1016/s0015-0282(16)54202-2

Clinical trials comparing nonsurgical transfer techniques with laparoscopic directed methods are needed to determine the most successful and cost-effective approach for gamete and ET. We report the successful nonsurgical transfer of frozen-…

rct 1989
American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(89)90870-3

In this double-blind study of changes in plasma lipid and lipoprotein concentrations during 6-month medical treatment of endometriosis, 53 patients were randomly assigned to one of four treatment schedules: danazol, 800 mg/day (n = 10); dan…

observational 1986
Fertility and sterility ·doi:10.1016/s0015-0282(16)49390-8

CA-125 is a cellular antigen detected in many patients with ovarian cancer, but it has also been detected in patients with endometriosis. Preoperative CA-125 levels were drawn from 113 patients before they underwent laparoscopy. Patients we…